ATE539739T1 - Getrocknetes, gemahlenes granulat und verfahren - Google Patents

Getrocknetes, gemahlenes granulat und verfahren

Info

Publication number
ATE539739T1
ATE539739T1 AT10001313T AT10001313T ATE539739T1 AT E539739 T1 ATE539739 T1 AT E539739T1 AT 10001313 T AT10001313 T AT 10001313T AT 10001313 T AT10001313 T AT 10001313T AT E539739 T1 ATE539739 T1 AT E539739T1
Authority
AT
Austria
Prior art keywords
dried ground
ground granules
particle size
granulate
granules
Prior art date
Application number
AT10001313T
Other languages
English (en)
Inventor
Sara Chastain
Walid Habib
Derek Moe
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Application granted granted Critical
Publication of ATE539739T1 publication Critical patent/ATE539739T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
  • Processing Of Solid Wastes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
AT10001313T 2005-08-30 2006-08-29 Getrocknetes, gemahlenes granulat und verfahren ATE539739T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71258005P 2005-08-30 2005-08-30
US11/507,240 US20070048373A1 (en) 2005-08-30 2006-08-21 Dried milled granulate and methods

Publications (1)

Publication Number Publication Date
ATE539739T1 true ATE539739T1 (de) 2012-01-15

Family

ID=37804492

Family Applications (2)

Application Number Title Priority Date Filing Date
AT10001313T ATE539739T1 (de) 2005-08-30 2006-08-29 Getrocknetes, gemahlenes granulat und verfahren
AT06813925T ATE458475T1 (de) 2005-08-30 2006-08-29 Getrocknetes, gemahlenes granulat und verfahren

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06813925T ATE458475T1 (de) 2005-08-30 2006-08-29 Getrocknetes, gemahlenes granulat und verfahren

Country Status (11)

Country Link
US (1) US20070048373A1 (de)
EP (3) EP1919454B1 (de)
JP (1) JP5144519B2 (de)
AT (2) ATE539739T1 (de)
CA (1) CA2621079C (de)
DE (1) DE602006012503D1 (de)
DK (1) DK2198855T3 (de)
ES (3) ES2379333T3 (de)
MX (1) MX2008002779A (de)
PT (1) PT2198855E (de)
WO (1) WO2007027720A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
CN1893956A (zh) * 2003-07-25 2007-01-10 沃纳奇尔科特公司 多西环素金属络合物固体剂型
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US7883039B2 (en) * 2007-02-27 2011-02-08 Collette Nv Continuous granulating and drying apparatus including measurement units
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
SG10201407965XA (en) * 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
TR201000688A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
FR2959130A1 (fr) * 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
JP6133009B2 (ja) * 2010-08-11 2017-05-24 協和発酵キリン株式会社 トピラマート顆粒
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
TR201009396A2 (tr) * 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Desloratadin granüller
KR101380836B1 (ko) * 2011-01-18 2014-04-09 한국기계연구원 상온진공과립분사 공정을 위한 취성재료 과립 및 이를 이용한 코팅층의 형성방법
JP5830412B2 (ja) * 2011-03-02 2015-12-09 ライオン株式会社 水難溶性薬物と賦形剤との粉砕物の製造方法、造粒粒子の製造方法、錠剤の製造方法
PL2736497T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
EP3013790A1 (de) 2013-06-27 2016-05-04 Mylan Laboratories Ltd. Verfahren zur herstellung von nepafenac
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
WO2015078891A1 (en) * 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
MX377527B (es) * 2015-10-27 2025-03-10 Shinetsu Chemical Co Éter de celulosa porosa no iónico soluble en agua que tiene excelente solubilidad y método para producir el mismo.
WO2022241159A1 (en) * 2021-05-12 2022-11-17 Spectrix Therapeutics, LLC Compositions and methods
EP4662041A1 (de) * 2023-02-06 2025-12-17 Novatec, Inc. Systeme und verfahren zur bestimmung der trocknungszeiten für granulatmaterialien auf basis des anfänglichen feuchtigkeitsgehalts der materialien

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
EP0662821A4 (de) * 1992-09-30 1996-02-28 Ascent Pharma Inc Calciumpolycarbophil-streupulver.
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
US6039275A (en) * 1996-07-04 2000-03-21 Holland Sweetener Company V.O.F. Aspartame powders for powder mixtures
PT1015352E (pt) * 1997-04-01 2007-09-24 Cima Labs Inc ''embalagem alveolar e comprimidos embalados''
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JPH1121236A (ja) * 1997-07-01 1999-01-26 Ohara Yakuhin Kogyo Kk ロキソプロフェン・ナトリウム固形製剤
US6387410B1 (en) * 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
DE19859636A1 (de) * 1998-12-23 2000-06-29 Hexal Ag Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
WO2001015668A1 (en) * 1999-09-02 2001-03-08 Nostrum Pharmaceuticals, Inc. Controlled release pellet formulation
KR100911779B1 (ko) * 2001-05-25 2009-08-12 세파론, 인코포레이티드 모다피닐을 포함하는 고형 제약 제제
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
US7207505B2 (en) * 2004-06-04 2007-04-24 Bender Martin P Method for producing small granules

Also Published As

Publication number Publication date
DE602006012503D1 (de) 2010-04-08
CA2621079C (en) 2014-02-18
PT2198855E (pt) 2012-03-19
JP2009505798A (ja) 2009-02-12
JP5144519B2 (ja) 2013-02-13
HK1160010A1 (en) 2012-08-10
DK2198855T3 (da) 2012-04-02
ES2379333T3 (es) 2012-04-25
EP1919454A2 (de) 2008-05-14
US20070048373A1 (en) 2007-03-01
EP2198855A1 (de) 2010-06-23
ATE458475T1 (de) 2010-03-15
ES2398637T3 (es) 2013-03-20
WO2007027720A3 (en) 2007-08-02
MX2008002779A (es) 2008-04-07
EP2198855B1 (de) 2012-01-04
CA2621079A1 (en) 2007-03-08
WO2007027720A2 (en) 2007-03-08
ES2339979T3 (es) 2010-05-27
EP2359811B1 (de) 2012-11-14
EP1919454B1 (de) 2010-02-24
EP2359811A1 (de) 2011-08-24
HK1111622A1 (en) 2008-08-15
HK1145146A1 (en) 2011-04-08

Similar Documents

Publication Publication Date Title
ATE458475T1 (de) Getrocknetes, gemahlenes granulat und verfahren
EP1608359A4 (de) Mit arzneimittel beladene teilchen mit tumor-target
DK1896006T3 (da) Fremstillingmetode for entacapon-holdige granuler til orale doseringsformet
FI20070521L (fi) Rakeita, tabletteja ja rakeistusmenetelmä
EP1599430A4 (de) Granulatförmiger dünger
EP1869106A4 (de) Janus-dendrimere und -dendrone
ATE552955T1 (de) Aufgespaltetes harzgranulat
EP1953177A4 (de) Methacrylharz und herstellungsverfahren dafür
DK1523329T3 (da) Viruspartikeladjuvant
DE602006012866D1 (de) Vorrichtung zum zuführen von pulver und granulat
FI20031635A0 (fi) Partikkelien erotusväline
EP1902068A4 (de) Egfr-inhibitoren als promotoren der neuritregeneration
GB2436766B (en) High bandgap arylene polymers
NL1031627A1 (nl) Acylaminobicyclische heteroaromatische verbindingen en toepassingen daarvan.
FR2891438B1 (fr) Procede antigerminatif de tubercules ou de bulbes utilisant l'eugenol et/ou l'isoeugenol.
DE602006006255D1 (de) Reifenlauffläche enthaltend Kern-Hülle-Teilchen
DE60332757D1 (de) Verbindungen, die sich als pestizide eignen
WO2007038407A3 (en) Compositions and methods for treating nervous system disorders
DE602006002898D1 (de) Verfahren zur Optimierung und Einstellung des Streuens, zugehörige Streuer und Computerprogramm
DE602006009327D1 (de) Verfahren zur Optimierung und Einstellung des Streuens, zugehörige Streuer und Computerprogramm
NL1028441A1 (nl) Wegbermbekleding.
FI20050322A0 (fi) Lannoitepartikkelituote, sen valmistus ja käyttö
Reinhart Ha-šmalī ha-yisra’ēlī bahar lěhit’abed
GB0513855D0 (en) Wet granulation process
ITMC20050068A1 (it) Procedimento per la produzione di granuli di polimero termoplastico ad uso industriale.